The landscape of global research and development is undergoing a seismic shift as the financial muscle of Big Tech begins…
Read More
FDA logs more than 1,700 adverse event reports involving compounded semaglutide and tirzepatide
The U.S. Food and Drug Administration (FDA) has officially documented over 1,700 adverse event reports linked to the use of…
Read More
AAPS PharmSci 360 Offers Fresh Insights for Industry Scientists
The pharmaceutical landscape is currently navigating a period of rapid transformation, driven by the integration of artificial intelligence, the rise…
Read More
FDA greenlights ViiV’s Tivicay PD for HIV-positive newborns in first month of life
The U.S. Food and Drug Administration (FDA) has officially granted approval for ViiV Healthcare’s Tivicay PD (dolutegravir) for the treatment…
Read More
Tufts model estimates 82x ROI and up to $21 million in value from Medable AI agent
The landscape of clinical drug development is undergoing a paradigm shift as the integration of agentic artificial intelligence (AI) moves…
Read More
Pharma tariffs reach smaller drugmakers as industry warns of R&D pressure
The landscape for pharmaceutical manufacturing in the United States underwent a seismic shift on September 29, as federal tariffs on…
Read More
As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
The landscape of modern drug development is currently undergoing a seismic shift, driven by an unprecedented explosion in data volume…
Read More
FDA issues final PDUFA meeting guidance, expands use of written responses
The U.S. Food and Drug Administration (FDA) has officially finalized its long-awaited guidance regarding formal meetings between the agency and…
Read More
Digital pathology’s next act: Mining old tissue to spare future animal studies
The landscape of preclinical research is undergoing a seismic shift as digital pathology transitions from a remote-work necessity to a…
Read More
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.
The landscape of hepatitis C (HCV) management has undergone a profound shift, yet a stark disconnect remains between clinical efficacy…
Read More
